Povidone
As of the edition of 20 October 2026, Povidone is a drug: marketed, first approved in 1994 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2016
- Kind
- Unknown
- Brand name
- Protagent SE
- First approved
- 28 January 1994 (CH)
- Approvals on record
- 3 in 3 regions
- Holder of the most recent approval
- Alcon; 2 holders in all
- Withdrawn from market
- 1 January 1978 (in some regions)
- Registered trials
- 3, 0 stopped early
- Disease areas
- Eye
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 4 | 3 | 3 | 0 | 0 |
| All trials | 3 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Alcon | Applicant | 1994 to now |